BACKGROUND: Obesity has been proposed as a risk factor for pancreatic cancer. METHODS: Pooled data were analyzed from the National Cancer Institute Pancreatic Cancer Cohort Consortium (PanScan) to study the association between prediagnostic anthropometric measures and risk of pancreatic cancer. PanScan applied a nested case-control study design and included 2170 cases and 2209 control subjects. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression for cohort-specific quartiles of body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]), weight, height, waist circumference, and waist to hip ratio as well as conventional BMI categories (underweight, <18.5; normal weight, 18.5-24.9; overweight, 25.0-29.9; obese, 30.0-34.9; and severely obese, > or = 35.0). Models were adjusted for potential confounders. RESULTS: In all of the participants, a positive association between increasing BMI and risk of pancreatic cancer was observed (adjusted OR for the highest vs lowest BMI quartile, 1.33; 95% CI, 1.12-1.58; P(trend) < .001). In men, the adjusted OR for pancreatic cancer for the highest vs lowest quartile of BMI was 1.33 (95% CI, 1.04-1.69; P(trend) < .03), and in women it was 1.34 (95% CI, 1.05-1.70; P(trend) = .01). Increased waist to hip ratio was associated with increased risk of pancreatic cancer in women (adjusted OR for the highest vs lowest quartile, 1.87; 95% CI, 1.31-2.69; P(trend) = .003) but less so in men. CONCLUSIONS: These findings provide strong support for a positive association between BMI and pancreatic cancer risk. In addition, centralized fat distribution may increase pancreatic cancer risk, especially in women.
BACKGROUND: Obesity has been proposed as a risk factor for pancreatic cancer. METHODS: Pooled data were analyzed from the National Cancer Institute Pancreatic Cancer Cohort Consortium (PanScan) to study the association between prediagnostic anthropometric measures and risk of pancreatic cancer. PanScan applied a nested case-control study design and included 2170 cases and 2209 control subjects. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression for cohort-specific quartiles of body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]), weight, height, waist circumference, and waist to hip ratio as well as conventional BMI categories (underweight, <18.5; normal weight, 18.5-24.9; overweight, 25.0-29.9; obese, 30.0-34.9; and severely obese, > or = 35.0). Models were adjusted for potential confounders. RESULTS: In all of the participants, a positive association between increasing BMI and risk of pancreatic cancer was observed (adjusted OR for the highest vs lowest BMI quartile, 1.33; 95% CI, 1.12-1.58; P(trend) < .001). In men, the adjusted OR for pancreatic cancer for the highest vs lowest quartile of BMI was 1.33 (95% CI, 1.04-1.69; P(trend) < .03), and in women it was 1.34 (95% CI, 1.05-1.70; P(trend) = .01). Increased waist to hip ratio was associated with increased risk of pancreatic cancer in women (adjusted OR for the highest vs lowest quartile, 1.87; 95% CI, 1.31-2.69; P(trend) = .003) but less so in men. CONCLUSIONS: These findings provide strong support for a positive association between BMI and pancreatic cancer risk. In addition, centralized fat distribution may increase pancreatic cancer risk, especially in women.
Authors: Bengt Isaksson; Fredrik Jonsson; Nancy L Pedersen; Jörgen Larsson; Maria Feychting; Johan Permert Journal: Int J Cancer Date: 2002-03-20 Impact factor: 7.396
Authors: Brenda K Edwards; Martin L Brown; Phyllis A Wingo; Holly L Howe; Elizabeth Ward; Lynn A G Ries; Deborah Schrag; Patricia M Jamison; Ahmedin Jemal; Xiao Cheng Wu; Carol Friedman; Linda Harlan; Joan Warren; Robert N Anderson; Linda W Pickle Journal: J Natl Cancer Inst Date: 2005-10-05 Impact factor: 13.506
Authors: Ute Nöthlings; Lynne R Wilkens; Suzanne P Murphy; Jean H Hankin; Brian E Henderson; Laurence N Kolonel Journal: Cancer Causes Control Date: 2007-01-11 Impact factor: 2.506
Authors: Robert R McWilliams; William R Bamlet; Mariza de Andrade; David N Rider; Julie M Cunningham; Gloria M Petersen Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-24 Impact factor: 4.254
Authors: A L Smith; C Bascuñana; A Hall; A Salman; A Z Andrei; A Volenik; H Rothenmund; D Ferland; D Lamoussenery; A S Kamath; R Amre; D Caglar; Z H Gao; D G Haegert; Y Kanber; R P Michel; G Omeroglu-Altinel; J Asselah; N Bouganim; P Kavan; G Arena; J Barkun; P Chaudhury; S Gallinger; W D Foulkes; A Omeroglu; P Metrakos; G Zogopoulos Journal: Curr Oncol Date: 2015-04 Impact factor: 3.677
Authors: Peter T Campbell; Christina C Newton; Cari M Kitahara; Alpa V Patel; Patricia Hartge; Jill Koshiol; Katherine A McGlynn; Hans-Olov Adami; Amy Berrington de González; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Neal D Freedman; Yu-Tang Gao; Graham G Giles; Marc J Gunter; Mazda Jenab; Linda M Liao; Roger L Milne; Kim Robien; Dale P Sandler; Catherine Schairer; Howard D Sesso; Xiao-Ou Shu; Elisabete Weiderpass; Alicja Wolk; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Susan M Gapstur Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-03-17 Impact factor: 4.254
Authors: Alexander P Stark; Hui-Hua Chang; Xiaoman Jung; Aune Moro; Kathleen Hertzer; Mu Xu; Andrea Schmidt; O Joe Hines; Guido Eibl Journal: Surgery Date: 2015-08-18 Impact factor: 3.982
Authors: Shannon M Lynch; Jacqueline M Major; Richard Cawthon; Stephanie J Weinstein; Jarmo Virtamo; Qing Lan; Nathaniel Rothman; Demetrius Albanes; Rachael Z Stolzenberg-Solomon Journal: Int J Cancer Date: 2013-06-14 Impact factor: 7.396